n-(3-pyridylmethyl)adriamycin has been researched along with thiazoles in 2 studies
| Studies (n-(3-pyridylmethyl)adriamycin) | Trials (n-(3-pyridylmethyl)adriamycin) | Recent Studies (post-2010) (n-(3-pyridylmethyl)adriamycin) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, LJ; Cheng, JQ; Dickey, CA; Gestwicki, JE; Guo, J; Jinwal, UK; Kiray, J; Koren, J; Li, X; Miyata, Y; Nguyen, L; O'Leary, JC | 1 |
| Chua, JP; Collins, CA; Gestwicki, JE; Klinedinst, S; Komiyama, T; Li, X; Lieberman, AP; Merry, DE; Miyata, Y; Morishima, Y; Osawa, Y; Peng, HM; Pratt, WB; Wang, AM | 1 |
2 other study(ies) available for n-(3-pyridylmethyl)adriamycin and thiazoles
| Article | Year |
|---|---|
Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.
Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridinium Compounds; Tamoxifen; Thiazoles | 2012 |
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation.
Topics: Animals; Dose-Response Relationship, Drug; Doxorubicin; Drosophila; Female; HEK293 Cells; HeLa Cells; HSP70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Chaperones; Muscular Disorders, Atrophic; Neurotoxins; PC12 Cells; Peptides; Protein Structure, Tertiary; Proteins; Pyridines; Rats; Receptors, Androgen; Thiazoles; Ubiquitination | 2013 |